Modulation of fibronectin extracellular matrix enhances anti-tumor efficacy of immune checkpoint blockade
Kabir A. Khan(Sunnybrook Health Science Centre), Robert S. Kerbel(Sunnybrook Health Science Centre), Weilan Ye, Patricia Himmels(Molecular Oncology (United States)), Robby M. Weimer(Sunesis (United States)), Alvin Gogineni(Angiogenesis Foundation), Grant Li(Molecular Oncology (United States)), William Cruz‐Muñoz(Sunnybrook Health Science Centre), Maresa Caunt Mitzner(Molecular Oncology (United States)), Robert Piskol(Bioinformatics Institute), Ping Xu(Sunnybrook Health Science Centre), H Kuo(Sunnybrook Health Science Centre), Iacovos P. Michael(Sunnybrook Health Science Centre), Annabelle Chow(Sunnybrook Health Science Centre), Rajiv Jesudason
Cited by 5
Related Papers
Tumor angiogenesis: past, present and the near future
|Carcinogenesis|2000|971
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
|Proceedings of the National Academy of Sciences|2010|666
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
|The Journal of Experimental Medicine|2014|353
Rapid Redistribution of Synaptic PSD-95 in the Neocortex In Vivo
|PLoS Biology|2006|340